Morepen Laboratories share news, announcements and annual reports
NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹119.31.
30 Oct: open ₹113.35, high ₹122.23, low ₹113.35
- Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,211 Cr1,108th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 32.94
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.50
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 14.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.22
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 88,57,838
Morepen Laboratories share news and announcements
608 announcements, routine notices left out, newest first. Page 8 of 13.
Dec 2019
Nov 2019
13 Nov · Results
13 Nov · Board meeting
Oct 2019
Sep 2019
26 Sep · Board meeting
25 Sep · Legal
24 Sep · Updates
19 Sep · Business
19 Sep · Board meeting
16 Sep · Board meeting
Aug 2019
13 Aug · Results
13 Aug · Board meeting
6 Aug · Board meeting
Jul 2019
May 2019
22 May · Analysts
9 May · Legal
The exchange asked on 9 May 2019
6 May · Analysts
4 May · Results
4 May · Board meeting
Apr 2019
26 Apr · Board meeting
Mar 2019
30 Mar · Management
30 Mar · Code of Conduct under SEBI(PIT) Reg., 2015
30 Mar · Board meeting
Feb 2019
4 Feb · Board meeting
4 Feb · Results
Jan 2019
23 Jan · Board meeting
Nov 2018
1 Nov · Results
1 Nov · Board meeting
Oct 2018
24 Oct · Board meeting
Sep 2018
28 Sep · Updates
25 Sep · Change in Company Secretary/Compliance Officer
21 Sep · Meeting
Aug 2018
13 Aug · Board meeting